A 47-year-old woman with three severe autoimmune diseases received CAR-T cell therapy at a German hospital, achieving one-year remission without further treatment. After years of failed...
Bristol Myers Squibb announced NHS funding for CAR-T therapy Breyanzi, enabling its use from April 1st in Spain for lymphoma treatment. It targets several aggressive subtypes...
Sarcomas are rare malignant tumors of connective tissue, representing a small cancer percentage but posing major treatment challenges. Advanced biotechnology, especially CAR-T immunotherapies, offers hope. CIBERONC...